Breaking News

BioDuro-Sundia Acquires Solid Dose Manufacturing Facility

US-based phase III commercial facility to support client base with large scale production of oral solid dosage forms.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BioDuro-Sundia, a drug discovery and development services organization, has acquired a 40,000 square foot commercial oral solid dose manufacturing facility located at 72 Fairbanks, Irvine, CA. BioDuro-Sundia expects to begin commercial service operations at the site on January 1, 2022.   “This fully-audited and operational facility allows us to immediately support our clients who require larger scale commercial production,” said Kent Payne, president, development and manufacturing US/EU at BioDu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters